Inventor · disambiguated record
Thomas Baumert
Also filed as: BAUMERT THOMAS · BAUMERT THOMAS F
9 granted patents·7 pending applications·44 citations·filing 1999–2024
85Inventor score
Files withUNIV STRASBOURG5INST NAT SANTE RECH MED4BAUMERT THOMAS3INSTITUT HOSPITALIER UNIV DE STRASBOURG2ALENTIS THERAPEUTICS AG1
Top patents by PatentIndex Score
16 records- 0188US11365251B2Humanized anti-claudin-1 antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2020·Granted Jun 21, 2022·2 cites·20 claims
- 0281US2025122279A1Humanized anti-claudin-1 antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0380US10851160B2Humanized anti-claudin-1 antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2017·Granted Dec 1, 2020·2 cites·12 claims
- 0478US10927170B2Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinomaINSTITUT HOSPITALIER UNIV DE STRASBOURG·Filed 2018·Granted Feb 23, 2021·3 cites·10 claims
- 0577US10815298B2Anti-claudin 1 monoclonal antibodies for the prevention and treatment of hepatocellular carcinomaINSTITUT HOSPITALIER UNIV DE STRASBOURG·Filed 2016·Granted Oct 27, 2020·3 cites·6 claims
- 0677US8518408B2Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis C virus infectionBAUMERT THOMAS·Filed 2009·Granted Aug 27, 2013·10 cites·22 claims
- 0772US2022411493A1Humanized anti-claudin-1 antibodies and uses thereofINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0868US10988737B2Clinical gene signature-based human cell culture model and uses thereofUNIV STRASBOURG·Filed 2016·Granted Apr 27, 2021·1 cites·15 claims
- 0961US12480096B2Clinical gene signature-based human cell culture model and uses thereofUNIV STRASBOURG·Filed 2021·Granted Nov 25, 2025·0 cites·4 claims
- 1060US2025326835A1Use of anti-claudin-1 antibodies to treat cholangiocarcinomaALENTIS THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 1156US6387662B1Synthesis and purification of hepatitis C virus-like particlesUS HEALTH·Filed 1999·Granted May 14, 2002·23 cites·11 claims
- 1254US2023349922A1H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and CancerUNIV STRASBOURG·Filed 2021·Application pending·0 cites
- 1348US2023138047A1Anti-claudin-1 monoclonal antibodies for the prevention and treatment of fibrotic diseasesUNIV STRASBOURG·Filed 2020·Application pending·0 cites
- 1442US8759010B2Host cell kinases as targets for antiviral therapies against HCV infectionBAUMERT THOMAS·Filed 2009·Granted Jun 24, 2014·0 cites·4 claims
- 1542US2023313299A1Method for diagnosis and/or prognosis of liver disease progression and risk of hepatocellular carcinoma and discovery of therapeutic compounds and targets to treat liver disease and cancerUNIV STRASBOURG·Filed 2021·Application pending·0 cites
- 1634US2013129676A1Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infectionBAUMERT THOMAS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Thomas Baumert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →